tiprankstipranks
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market

Phathom Pharmaceuticals (PHAT) Technical Analysis

Compare
392 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
3Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Phathom Pharmaceuticals’s (PHAT) Moving Averages Convergence Divergence (MACD) indicator is 0.21, suggesting Phathom Pharmaceuticals is a Sell.
Phathom Pharmaceuticals’s (PHAT) 20-Day exponential moving average is 5.91, while Phathom Pharmaceuticals’s (PHAT) share price is $6.6, making it a Buy.
Phathom Pharmaceuticals’s (PHAT) 50-Day exponential moving average is 6.29, while Phathom Pharmaceuticals’s (PHAT) share price is $6.6, making it a Buy.

Phathom Pharmaceuticals (PHAT) Pivot Points

Apr 01, 2025, 03:02 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.04
6.19
6.44
6.59
6.84
6.99
7.24
Fibonacci
6.19
6.34
6.44
6.59
6.74
6.84
6.99
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Phathom Pharmaceuticals (PHAT) Moving Averages

Apr 01, 2025, 03:02 AM
Period
Simple
Exponential
MA5
6.53Buy
6.47Buy
MA10
6.16Buy
6.18Buy
MA20
5.61Buy
5.91Buy
MA50
5.87Buy
6.29Buy
MA100
7.73Sell
7.73Sell
MA200
10.94Sell
9.58Sell
Phathom Pharmaceuticals’s (PHAT) 10-Day exponential moving average is 6.18, while Phathom Pharmaceuticals’s (PHAT) share price is $6.6, making it a Buy.
Phathom Pharmaceuticals’s (PHAT) 100-Day exponential moving average is 7.73, while Phathom Pharmaceuticals’s (PHAT) share price is $6.6, making it a Sell.
Phathom Pharmaceuticals’s (PHAT) stock price is $6.6 and Phathom Pharmaceuticals’s (PHAT) 50-day simple moving average is 5.87, creating a Buy signal.
Phathom Pharmaceuticals’s (PHAT) stock price is $6.6 and Phathom Pharmaceuticals’s (PHAT) 100-day simple moving average is 7.73, creating a Sell signal.
Phathom Pharmaceuticals’s (PHAT) stock price is $6.6 and Phathom Pharmaceuticals’s (PHAT) 200-day simple moving average is 10.94, creating a Sell signal.

Phathom Pharmaceuticals (PHAT) Technical Indicators

Apr 01, 2025, 03:02 AM
Name
Value
Implied Action
RSI (14)
59.60
Neutral
STOCH (9,6)
91.73
Sell
STOCHRSI (14)
93.45
Sell
MACD (12,26)
0.21
Sell
ADX (14)
24.89
Neutral
Williams %R
-10.28
Sell
CCI (14)
100.87
Sell
ATR (14)
0.55
-
Ultimate Oscillator
65.05
Neutral
ROC
50.00
Buy
Phathom Pharmaceuticals’s (PHAT) Relative Strength Index (RSI) is 59.60, creating a Neutral signal.
Phathom Pharmaceuticals’s (PHAT) Trend Strength Indicator (ADX) is 24.89, creating a Neutral signal.
Phathom Pharmaceuticals’s (PHAT) Commodity Channel Index (CCI) is 100.87, creating a Sell signal.
Phathom Pharmaceuticals’s (PHAT) Price Rate of Change (ROC) is 50.00, creating a Buy signal.

FAQ

Is PHAT a Buy, Hold, or Sell?
Based on PHAT’s technical indicators, PHAT is a Hold.
    What is PHAT’s RSI (14)?
    PHAT’s RSI (14) is 59.60, which suggests PHAT is a Neutral.
      What is PHAT’s MACD?
      PHAT’s MACD is 0.21, which suggests PHAT is a Sell.
        What is PHAT’s 5-day moving average?
        PHAT’s 5-day moving average is 6.53, which suggests PHAT is a Buy.
          What is PHAT’s 20-day moving average?
          PHAT 20-day moving average is 5.61, which suggests PHAT is a Buy.
            What is PHAT’s 50-day moving average?
            PHAT’s 50-day moving average is 5.87, which suggests PHAT is a Buy.
              What is PHAT’s 200-day moving average?
              PHAT’s 200-day moving average is 10.94, which suggests PHAT is a Sell.
                What is PHAT’s Williams % R (14)?
                PHAT’s Williams % R (14) is -10.28, which suggests PHAT is a Sell.
                  What is PHAT’s CCI (14)?
                  PHAT’s CCI (14) is 100.87, which suggests PHAT is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis